Frias JP, Nauck MA, Van J, Benson C, et al. Efficacy and Tolerability of Tirzepatide, a Dual GIP and GLP-1 Receptor Agonist
in Patients with Type 2 Diabetes: A 12-Week, Randomised, Double-Blind,
Placebo-Controlled Study to Evaluate Different Dose-Escalation Regimens. Diabetes Obes Metab 2020 Jan 27. doi: 10.1111/dom.13979.
PMID: 31984598